A 20mg vial of Sermorelin delivers a high-mass lyophilized yield optimized for continuous, high-throughput in vitro screens and multi-animal preclinical study protocols. This guide outlines physical vial specifications, exact reconstitution volume calculations, aliquot stabilization protocols, and lot-matched analytical verification standards required for rigorous laboratory research.
A 20mg vial of Sermorelin delivers a high-mass lyophilized yield optimized for continuous, high-throughput in vitro screens and multi-animal preclinical study protocols. This guide outlines physical vial specifications, exact reconstitution volume calculations, aliquot stabilization protocols, and lot-matched analytical verification standards required for rigorous laboratory research.
Sermorelin Acetate (GHRH 1-29 amide) is a synthetic 29-amino acid peptide representing the biologically active N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH 1-44). In laboratory research settings, a 20mg vial format represents a high-density, bulk-lyophilized unit specifically formatted for high-volume research institutions, automated liquid handling systems, and multi-specimen rodent studies.
Each 20mg vial consists of a sterile, vacuum-sealed, white to off-white cake formed via controlled freeze-drying under an inert nitrogen blanket. While PX1 Research routinely provides standard single-experiment stock sizes—such as 2mg, 5mg, and 10mg formats available directly on our sermorelin product page—the 20mg fill size is tailored for laboratories requiring substantial material from a single manufacturing lot to eliminate lot-to-lot variance during longitudinal trials.
Sermorelin features the specific primary sequence: NH2-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2, with a calculated molecular weight of 3357.9 Da. Preclinical models demonstrate that this truncated sequence retains full receptor-binding affinity for the growth hormone-releasing hormone receptor (GHRH-R) located on pituitary somatotropes.
In vitro data indicate that Sermorelin binding activates the G-protein-coupled receptor pathway, stimulating adenylate cyclase and inducing intracellular cyclic adenosine monophosphate (cAMP) accumulation. This downstream cascade activates protein kinase A (PKA), triggering targeted transcriptional events and exocytosis of growth hormone storage vesicles. Because Sermorelin lacks the 15 C-terminal amino acids of native GHRH(1-44), it serves as a primary reference standard for studying minimum active sequence domains in receptor-ligand kinetics.
Reconstituting a 20mg lyophilized vial requires precise calculations to ensure desired target concentrations and uniform volumetric delivery across cellular microplates or micro-dosing apparatuses. Researchers must select an appropriate diluent volume based on the working concentration needed for specific assay pipetting limits.
The mathematical formula to determine concentration ($C$) is total peptide mass ($M$) divided by added diluent volume ($V$): $C = M / V$. Below are standard reconstitution outcomes when adding diluent to a 20mg Sermorelin vial:
• 1.0 mL Diluent Volume: Yields a stock concentration of 20.0 mg/mL (20,000 µg/mL; 20 µg/µL). Highly concentrated; recommended for micro-aliquoting or stock solutions intended for high-ratio serial dilutions.
• 2.0 mL Diluent Volume: Yields a stock concentration of 10.0 mg/mL (10,000 µg/mL; 10 µg/µL). Standard concentration for automated microplate dispensing and precise volumetric transfer.
• 3.0 mL Diluent Volume: Yields a stock concentration of 6.67 mg/mL (6,667 µg/mL; 6.67 µg/µL). Suitable for mid-range volumetric protocols requiring lower concentration error margins.
• 4.0 mL Diluent Volume: Yields a stock concentration of 5.0 mg/mL (5,000 µg/mL; 5.0 µg/µL). Facilitates broader volumetric measurement in multi-subject preclinical rodent cohorts.
To rapidly verify custom volumetric ratios, unit conversions, or liquid handler offsets, researchers should utilize the interactive PX1 reconstitution calculator prior to reconstituting dry laboratory stock.
Because a 20mg vial produces a large volume of active solution, proper aliquot management is essential to prevent degradation. Repeated freeze-thaw cycles subject peptide chains to mechanical shear stress, ice crystal formation, and solution pH shifts, leading to peptide bond cleavage, aggregation, or precipitation.
Upon full dissolution using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile PBS, the solution should immediately be divided into single-use micro-aliquots under a laminar flow hood. Utilize sterile, low-binding polypropylene microcentrifuge tubes to minimize hydrophobic binding of peptide molecules to container walls. Store individual aliquots at -80°C for long-term preservation, thawing only the exact working volume required for a single experimental run.
Unreconstituted, lyophilized Sermorelin 20mg vials remain stable when maintained under temperature-controlled conditions. For long-term preservation up to 24 months, store dry vials in a dark freezer environment between -20°C and -80°C. Vials should be kept in original packaging with desiccant to prevent ambient moisture ingress.
Following reconstitution with bacteriostatic water, liquid stock solution may be stored at 2°C to 8°C for up to 28 days. Avoid high-amplitude vortexing or aggressive agitation when dissolving the cake; gentle, manual side-to-side rotation ensures rapid solubility without inducing mechanical denaturing or bubble entrapment.
To ensure reproducible experimental outcomes, every batch of Sermorelin manufactured for PX1 Research undergoes strict third-party analytical testing. High-Performance Liquid Chromatography (HPLC) is employed to verify chemical purity, establishing that the sample meets or exceeds the mandatory ≥98.0% purity threshold.
Mass Spectrometry (MS) confirms exact molecular identity by verifying the expected monoisotopic mass of 3357.9 Da without structural variants or truncated impurities. Additionally, Limulus Amebocyte Lysate (LAL) testing is performed on every lot to enforce stringent endotoxin limits (<0.5 EU/mg), ensuring that reconstituted solutions will not cause non-specific inflammatory responses in sensitive cell cultures or animal models. Researchers can retrieve lot-matched analytical documentation anytime through our online certificate of analysis portal.
Selecting between a 20mg high-mass vial and standard sizes depends on assay scale, experimental timelines, and liquid stability requirements. High-throughput facilities conducting extended parallel receptor binding assays benefit from 20mg fills due to lower unit-mass variance and reduced container overhead.
Conversely, pilot studies, short-duration assays, or laboratories testing single acute responses may prefer 2mg, 5mg, or 10mg formats. Utilizing smaller fill sizes prevents reconstituted solution from sitting in cold storage past optimal stability windows. Principal investigators can review all available formulation sizes within our full catalog of all research peptides to align vial selection with project scale.
Sermorelin acts directly as a targeted GHRH receptor agonist, imitating native GHRH activity. When designing comparative pituitary signaling studies, researchers frequently evaluate Sermorelin against alternative secretagogues and modified peptide structures.
For example, selective ghrelin receptor agonists like ipamorelin target the growth hormone secretagogue receptor (GHSR-1a) rather than the GHRH receptor, evoking distinct intracellular pathway dynamics. Within the GHRH class, modified analogues like cjc-1295-no-dac feature specific amino acid substitutions to resist enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV). Similarly, tesamorelin—a GHRH derivative incorporating a trans-3-hexenoic acid group—demonstrates modified metabolic stability profiles during comparative lipolysis research in preclinical rodent models.
In cell culture models utilizing primary rat pituitary somatotropes or immortalized GH3 cell lines, reconstituted Sermorelin is applied to evaluate direct gene expression, receptor desensitization, and hormone release kinetics. In vitro assays typically employ working concentrations ranging from 1 nM to 100 nM.
Researchers measuring intracellular cAMP generation, calcium flux, or downstream IGF-1 gene transcription must account for molecular degradation rates in culture media. Reference technical papers, buffer formulation guides, and assay design frameworks are published regularly within the PX1 research library to support experimental reproducibility.
PX1 Research enforces rigorous manufacturing and distribution standards across our entire chemical inventory. All research compounds are synthesized in state-of-the-art, GMP-compliant facilities located in the United States and analyzed by independent ISO 17025 accredited laboratories.
Orders are fulfilled directly from our temperature-controlled California and Arizona distribution hubs, offering same-day shipping for orders placed Monday through Friday before 3:00 PM PST. Multi-investigator laboratories, university departments, and institutional buyers requiring custom synthesis, specific fill sizes, or bulk volume allocations can establish dedicated supply workflows via wholesale research accounts.
What is the exact chemical structure and mass of Sermorelin in a 20mg vial?
Sermorelin Acetate is a 29-amino acid peptide representing the active GHRH(1-29) sequence, with a chemical formula of C149H246N44O42S and a theoretical molecular weight of 3357.9 Da. A 20mg vial contains 20 milligrams of pure lyophilized peptide cake.
How do I calculate diluent volume for a 20mg Sermorelin vial?
Divide the 20mg total mass by your target concentration. For example, adding 2.0 mL of diluent yields 10 mg/mL (10 µg/µL), while adding 4.0 mL yields 5 mg/mL (5 µg/µL).
What diluent should be used for reconstituting Sermorelin 20mg for multi-week research?
Bacteriostatic water (0.9% benzyl alcohol) is recommended for multi-use reconstituted vials stored at 2°C to 8°C up to 28 days. For immediate, single-day cellular assays, sterile 0.9% sodium chloride or PBS may be utilized.
How does PX1 Research verify the purity of Sermorelin 20mg lots?
Each lot undergoes analytical High-Performance Liquid Chromatography (HPLC) to confirm ≥98.0% purity and Mass Spectrometry (MS) to verify molecular weight. Endotoxin levels are verified below <0.5 EU/mg via LAL testing.
Can reconstituted Sermorelin 20mg stock solution be refrozen?
Repeated freeze-thaw cycles of liquid solutions cause peptide degradation. It is strongly recommended to sub-aliquot the newly reconstituted solution into single-use polypropylene tubes prior to freezing at -80°C.
Does PX1 Research keep 20mg Sermorelin vials in standard stock?
PX1 Research maintains standard stock in 2mg, 5mg, and 10mg vial sizes on our main product pages. The 20mg format is supplied upon request for bulk institutional orders or custom laboratory production runs.
Why is Sermorelin truncated to 29 amino acids instead of the full 44?
Preclinical receptor-binding studies proved that the N-terminal 1-29 sequence retains full biological activity and binding affinity for the GHRH receptor, making the additional 15 C-terminal residues redundant for signal transduction research.
What is the recommended storage temperature for lyophilized Sermorelin vials?
Unreconstituted lyophilized vials should be stored at -20°C to -80°C in a dry, dark environment. Protected from light and moisture, dry cakes remain stable for up to 24 months.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.